Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Daiichi Sankyo Inc. |
---|---|
Information provided by: | Daiichi Sankyo Inc. |
ClinicalTrials.gov Identifier: | NCT00403481 |
This study will examine the ability of olmesartan medoxomil to lower the blood pressure of patients with Type II diabetes and high blood pressure. The medication being tested has been approved by the FDA for the treatment of high blood pressure.
Condition | Intervention | Phase |
---|---|---|
Hypertension |
Drug: Olmesartan medoxomil Drug: Olmesartan medoxomil plus Hydrochlorothyazide |
Phase IV |
Study Type: | Interventional |
Study Design: | Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Safety/Efficacy Study |
Official Title: | A Prospective, Open Label, Single Arm Study to Evaluate the Safety and Efficacy of an Olmesartan Medoxomil Based Treatment Regimen in Type II Diabetic Patients With Hypertension |
Estimated Enrollment: | 200 |
Study Start Date: | November 2006 |
Study Completion Date: | December 2007 |
Estimated Primary Completion Date: | November 2007 (Final data collection date for primary outcome measure) |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Responsible Party: | Daiichi Sankyo ( William Waverczak ) |
Study ID Numbers: | 866-449 |
Study First Received: | November 22, 2006 |
Last Updated: | October 7, 2008 |
ClinicalTrials.gov Identifier: | NCT00403481 |
Health Authority: | United States: Food and Drug Administration |
Hypertension Angiotensin Receptor Blocker Calcium Channel Blocker Angiotensin Converting Enzyme Inhibitor |
Hydrochlorothyazide Stage I and II Hypertension Type II Diabetes |
Calcium, Dietary Diabetes Mellitus, Type 2 Vascular Diseases Diabetes Mellitus |
Olmesartan medoxomil Angiotensin II Hypertension |
Angiotensin II Type 1 Receptor Blockers Molecular Mechanisms of Pharmacological Action Therapeutic Uses Cardiovascular Diseases |
Cardiovascular Agents Antihypertensive Agents Pharmacologic Actions |